Cargando…
Peptide 17 alleviates early hypertensive renal injury by regulating the Hippo/YAP signalling pathway
AIM: Hypertensive nephropathy is embodied by kidney tissue fibrosis and glomerular sclerosis, as well as renal inflammation. The Hippo/YAP (yes‐associated protein, YAP) axis has been reported to promote inflammation and fibrosis and may participate in the pathogenesis of heart, vascular and renal in...
Autores principales: | Xu, San‐Bin, Xu, Bin, Ma, Zhi‐Heng, Huang, Mei‐Qin, Gao, Zhi‐Sheng, Ni, Jian‐Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544900/ https://www.ncbi.nlm.nih.gov/pubmed/35608936 http://dx.doi.org/10.1111/nep.14066 |
Ejemplares similares
-
Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
por: Wang, Dong-Yu, et al.
Publicado: (2016) -
YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019) -
αCGRP Affects BMSCs’ Migration and Osteogenesis via the Hippo-YAP
Pathway
por: Wang, Bin, et al.
Publicado: (2019) -
Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018) -
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)